Apellis Pharmaceuticals Stock (NASDAQ: APLS) stock price, news, charts, stock research, profile.
Open | $39.42 |
Close | $40.11 |
Volume / Avg. | 537.46K / 1.47M |
Day Range | $39.42 - $40.68 |
52 Wk Range | 30.57 - 73.80 |
Market Cap | $4.88B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 18.04% |
Days to Cover | 11.59 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Apellis Pharmaceuticals (NASDAQ:APLS) through any online brokerage.
Other companies in Apellis Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), Ionis Pharmaceuticals (NASDAQ:IONS) and Alkermes (NASDAQ:ALKS).
Apellis Pharmaceuticals has a consensus price target of $74.47.
The stock price for Apellis Pharmaceuticals (NASDAQ: APLS) is $40.11 last updated August 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Apellis Pharmaceuticals.
Apellis Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
There is no upcoming split for Apellis Pharmaceuticals.
Apellis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.